[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 2, Issue 4 (Summer 2005) ::
Sci J Iran Blood Transfus Organ 2005, 2(4): 115-122 Back to browse issues page
Prevalence of hepatitis B and C in thalassemic patients of East Azarbaijan in 2003
S.E. Torabi , K. Abed Ashtiani , R. Dehkhoda , A.N. Moghadam , R. Sorkhabi , M.K. Bahram , J. Babaei
Abstract:   (29509 Views)

  Abstract

  

 Background and Objectives

  Patients with major b -thalassemia have been exposed to a wide range of blood-borne viruses among which hepatitis B and C viruses have a considerable importance. In this study, seroprevalence and risk factor of HBV, HCV and HIV infections among thalassemic patients of East Azarbaijan were evaluated.

 

  Materials and Methods

  Eighty four thalassemic patients who were regularly transfused at Children Hospital (Tabriz) enrolled in this observational study. Some data were collected through questionnaires and patients’ medical history then, patients were evaluated for the presence of HCVAb, HBsAg, HIVAb, HBsAb, HBcAb and ferritin by ELISA moreover, HCV positive sera were confirmed by Recombinant Immunoblot Assay (RIBA-3.0).

 

 Results

 None of the eighty-four thalassemic patients were HIV and HBV positive however, 6 (7.1%) were HCV positive. Distribution of sex and the mean ferritin did not differ from HCV-positive to HCV-negative patients, but the age average was significantly higher in HCV-positive patients (p<0.001). Moreover, HCV-positive patients had a significantly longer history of transfusion compared with HCV-negative patients (p<0.001).

 The prevalence of HCV in those patients who had received their first blood transfusion before the implementation of compulsory testing for HCV in 1995 was significantly lower. In other words, no case became infected after the initiation of donor screening test for HCV.

 

 Conclusions

  The prevalence of HCV in thalassemic patients of East Azarbaijan was lower compared to other provinces of Iran and all positive cases in this study went back to the time period preceeding 1995 that is before the implementation of compulsory HCV screening tests.

  

  

 Key words: Major thalassemia , Hepatitis B, Hepatitis C

Keywords: Major thalassemia, Hepatitis B, Hepatitis C
Full-Text [PDF 352 kb]   (2839 Downloads)    
Type of Study: Research | Subject: General
Published: 2014/06/30
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Torabi S, Abed Ashtiani K, Dehkhoda R, Moghadam A, Sorkhabi R, Bahram M et al . Prevalence of hepatitis B and C in thalassemic patients of East Azarbaijan in 2003. Sci J Iran Blood Transfus Organ 2005; 2 (4) :115-122
URL: http://bloodjournal.ir/article-1-34-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 4 (Summer 2005) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645